CONTEXT: Attention-deficit/hyperactivity disorder (ADHD) is associated with widespread cognitive impairments, but it is not known whether the apparent multiple impairments share etiological roots or separate etiological pathways exist. A better understanding of the etiological pathways is important for the development of targeted interventions and for identification of suitable intermediate phenotypes for molecular genetic investigations. OBJECTIVES: To determine, by using a multivariate familial factor analysis approach, whether 1 or more familial factors underlie the slow and variable reaction times, impaired response inhibition, and choice impulsivity associated with ADHD. DESIGN: An ADHD and control sibling-pair design. SETTING: Belgium, Germany, Ireland, Israel, Spain, Switzerland, and the United Kingdom. PARTICIPANTS: A total of 1265 participants, aged 6 to 18 years: 464 probands with ADHD and 456 of their siblings (524 with combined-subtype ADHD), and 345 control participants. MAIN OUTCOME MEASURES: Performance on a 4-choice reaction time task, a go/no-go inhibition task, and a choice-delay task. RESULTS: The final model consisted of 2 familial factors. The larger factor, reflecting 85% of the familial variance of ADHD, captured 98% to 100% of the familial influences on mean reaction time and reaction time variability. The second, smaller factor, reflecting 13% of the familial variance of ADHD, captured 62% to 82% of the familial influences on commission and omission errors on the go/no-go task. Choice impulsivity was excluded in the final model because of poor fit. CONCLUSIONS: The findings suggest the existence of 2 familial pathways to cognitive impairments in ADHD and indicate promising cognitive targets for future molecular genetic investigations. The familial distinction between the 2 cognitive impairments is consistent with recent theoretical models--a developmental model and an arousal-attention model--of 2 separable underlying processes in ADHD. Future research that tests the familial model within a developmental framework may inform developmentally sensitive interventions.
CONTEXT: Attention-deficit/hyperactivity disorder (ADHD) is associated with widespread cognitive impairments, but it is not known whether the apparent multiple impairments share etiological roots or separate etiological pathways exist. A better understanding of the etiological pathways is important for the development of targeted interventions and for identification of suitable intermediate phenotypes for molecular genetic investigations. OBJECTIVES: To determine, by using a multivariate familial factor analysis approach, whether 1 or more familial factors underlie the slow and variable reaction times, impaired response inhibition, and choice impulsivity associated with ADHD. DESIGN: An ADHD and control sibling-pair design. SETTING: Belgium, Germany, Ireland, Israel, Spain, Switzerland, and the United Kingdom. PARTICIPANTS: A total of 1265 participants, aged 6 to 18 years: 464 probands with ADHD and 456 of their siblings (524 with combined-subtype ADHD), and 345 control participants. MAIN OUTCOME MEASURES: Performance on a 4-choice reaction time task, a go/no-go inhibition task, and a choice-delay task. RESULTS: The final model consisted of 2 familial factors. The larger factor, reflecting 85% of the familial variance of ADHD, captured 98% to 100% of the familial influences on mean reaction time and reaction time variability. The second, smaller factor, reflecting 13% of the familial variance of ADHD, captured 62% to 82% of the familial influences on commission and omission errors on the go/no-go task. Choice impulsivity was excluded in the final model because of poor fit. CONCLUSIONS: The findings suggest the existence of 2 familial pathways to cognitive impairments in ADHD and indicate promising cognitive targets for future molecular genetic investigations. The familial distinction between the 2 cognitive impairments is consistent with recent theoretical models--a developmental model and an arousal-attention model--of 2 separable underlying processes in ADHD. Future research that tests the familial model within a developmental framework may inform developmentally sensitive interventions.
Authors: Alysa E Doyle; Erik G Willcutt; Larry J Seidman; Joseph Biederman; Virginie-Anne Chouinard; Julie Silva; Stephen V Faraone Journal: Biol Psychiatry Date: 2005-06-01 Impact factor: 13.382
Authors: F V Rijsdijk; N E M van Haren; M M Picchioni; C McDonald; T Toulopoulou; H E Hulshoff Pol; R S Kahn; R Murray; P C Sham Journal: Psychol Med Date: 2005-10 Impact factor: 7.723
Authors: Katherine A Johnson; Simon P Kelly; Mark A Bellgrove; Edwina Barry; Marie Cox; Michael Gill; Ian H Robertson Journal: Neuropsychologia Date: 2006-12-08 Impact factor: 3.139
Authors: Katherine A Johnson; Edwina Barry; Mark A Bellgrove; Marie Cox; Simon P Kelly; Aoife Dáibhis; Michael Daly; Michelle Keavey; Amy Watchorn; Michael Fitzgerald; Fiona McNicholas; Aiveen Kirley; Ian H Robertson; Michael Gill Journal: Neuropsychologia Date: 2008-01-12 Impact factor: 3.139
Authors: Wai Chen; Kaixin Zhou; Pak Sham; Barbara Franke; Jonna Kuntsi; Desmond Campbell; Karin Fleischman; Jo Knight; Penny Andreou; Renée Arnold; Marieke Altink; Frits Boer; Mary Jane Boholst; Cathelijne Buschgens; Louise Butler; Hanna Christiansen; Ellen Fliers; Raoul Howe-Forbes; Isabel Gabriëls; Alexander Heise; Isabelle Korn-Lubetzki; Rafaela Marco; She'era Medad; Ruud Minderaa; Ueli C Müller; Aisling Mulligan; Lamprini Psychogiou; Nanda Rommelse; Vaheshta Sethna; Henrik Uebel; Peter McGuffin; Robert Plomin; Tobias Banaschewski; Jan Buitelaar; Richard Ebstein; Jacques Eisenberg; Michael Gill; Iris Manor; Ana Miranda; Fernando Mulas; Robert D Oades; Herbert Roeyers; Aribert Rothenberger; Joseph Sergeant; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Eric Taylor; Margaret Thompson; Stephen V Faraone; Philip Asherson Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-12-05 Impact factor: 3.568
Authors: Penny Andreou; Ben M Neale; Wai Chen; Hanna Christiansen; Isabel Gabriels; Alexander Heise; Sheera Meidad; Ueli C Muller; Henrik Uebel; Tobias Banaschewski; Iris Manor; Robert Oades; Herbert Roeyers; Aribert Rothenberger; Pak Sham; Hans-Christoph Steinhausen; Philip Asherson; Jonna Kuntsi Journal: Psychol Med Date: 2007-05-31 Impact factor: 7.723
Authors: Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi Journal: Neuropsychopharmacology Date: 2010-08-25 Impact factor: 7.853
Authors: Yannis Paloyelis; Mitul A Mehta; Stephen V Faraone; Philip Asherson; Jonna Kuntsi Journal: J Am Acad Child Adolesc Psychiatry Date: 2012-06-05 Impact factor: 8.829
Authors: Tomasz Schneider; Nicholas Ilott; Giovana Brolese; Lisiane Bizarro; Philip J E Asherson; Ian P Stolerman Journal: Neuropsychopharmacology Date: 2011-02-02 Impact factor: 7.853
Authors: Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson Journal: BMC Psychiatry Date: 2010-09-03 Impact factor: 3.630
Authors: J Crosbie; P Arnold; A Paterson; J Swanson; A Dupuis; X Li; J Shan; T Goodale; C Tam; L J Strug; R J Schachar Journal: J Abnorm Child Psychol Date: 2013-04
Authors: Tobias Banaschewski; Christine Jennen-Steinmetz; Daniel Brandeis; Jan K Buitelaar; Jonna Kuntsi; Luise Poustka; Joseph A Sergeant; Edmund J Sonuga-Barke; Alexis C Frazier-Wood; Björn Albrecht; Wai Chen; Henrik Uebel; Wolff Schlotz; Jaap J van der Meere; Michael Gill; Iris Manor; Ana Miranda; Fernando Mulas; Robert D Oades; Herbert Roeyers; Aribert Rothenberger; Hans-Christoph Steinhausen; Stephen V Faraone; Philip Asherson Journal: J Child Psychol Psychiatry Date: 2012-08-06 Impact factor: 8.982